Gw&K Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Gw&K Investment Management, LLC

$11.8 Billion
Q4 2024

A detailed history of Gw&K Investment Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,206,350 shares of SUPN stock, worth $45.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

1,206,350

Previous 1,238,015 2.56%

Holding current value

$45.8 Million

Previous $38.6 Million 13.0%

% of portfolio

0.37%

Previous 0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$31.89 - $37.83 $1.01 Million - $1.2 Million	-31,665 Reduced 2.56%	1,206,350 $43.6 Million
Q3 2024 Nov 07, 2024	SELL	$25.77 - $35.16 $1.43 Million - $1.94 Million	-55,300 Reduced 4.28%	1,238,015 $38.6 Million
Q2 2024 Aug 12, 2024	SELL	$25.99 - $33.85 $1.2 Million - $1.56 Million	-46,127 Reduced 3.44%	1,293,315 $34.6 Million
Q1 2024 May 08, 2024	BUY	$27.11 - $35.17 $594,142 - $770,785	21,916 Added 1.66%	1,339,442 $45.7 Million
Q4 2023 Feb 09, 2024	SELL	$22.72 - $29.68 $2.01 Million - $2.63 Million	-88,632 Reduced 6.3%	1,317,526 $38.1 Million
Q3 2023 Nov 09, 2023	BUY	$27.57 - $32.91 $190,315 - $227,177	6,903 Added 0.49%	1,406,158 $38.8 Million
Q2 2023 Aug 09, 2023	SELL	$29.91 - $38.73 $503,953 - $652,561	-16,849 Reduced 1.19%	1,399,255 $42.1 Million
Q1 2023 May 09, 2023	BUY	$34.93 - $42.03 $334,489 - $402,479	9,576 Added 0.68%	1,416,104 $51.3 Million
Q4 2022 Feb 10, 2023	SELL	$31.09 - $37.88 $11.2 Million - $13.7 Million	-360,961 Reduced 20.42%	1,406,528 $50.2 Million
Q3 2022 Nov 09, 2022	SELL	$28.79 - $35.41 $4.1 Million - $5.04 Million	-142,360 Reduced 7.45%	1,767,489 $59.8 Million
Q2 2022 Aug 09, 2022	BUY	$25.33 - $34.25 $2.1 Million - $2.83 Million	82,758 Added 4.53%	1,909,849 $55.2 Million
Q1 2022 May 09, 2022	SELL	$28.51 - $32.9 $267,281 - $308,437	-9,375 Reduced 0.51%	1,827,091 $59.1 Million
Q4 2021 Feb 11, 2022	BUY	$26.37 - $34.22 $5.56 Million - $7.22 Million	210,976 Added 12.98%	1,836,466 $53.6 Million
Q3 2021 Nov 10, 2021	BUY	$23.54 - $31.39 $221,040 - $294,752	9,390 Added 0.58%	1,625,490 $43.4 Million
Q2 2021 Aug 10, 2021	BUY	$26.72 - $33.19 $1.14 Million - $1.42 Million	42,689 Added 2.71%	1,616,100 $49.8 Million
Q1 2021 May 11, 2021	BUY	$24.15 - $31.45 $6.18 Million - $8.05 Million	256,071 Added 19.44%	1,573,411 $41.2 Million
Q4 2020 Feb 05, 2021	BUY	$17.7 - $25.81 $4.73 Million - $6.9 Million	267,452 Added 25.47%	1,317,340 $33.1 Million
Q3 2020 Nov 10, 2020	BUY	$20.2 - $25.05 $5.23 Million - $6.49 Million	259,087 Added 32.76%	1,049,888 $21.9 Million
Q2 2020 Aug 06, 2020	BUY	$17.09 - $24.89 $13.5 Million - $19.7 Million	790,801 New	790,801 $18.8 Million

Others Institutions Holding SUPN

# of Institutions

293

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.03B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account

Gw&K Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History